These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 8020378)
1. [Growth inhibitory action of RGNTF-McAb on human retinoblastoma cell line Y-79]. Zhou MH; Ren F Zhonghua Yan Ke Za Zhi; 1993 Nov; 29(6):349-52. PubMed ID: 8020378 [TBL] [Abstract][Full Text] [Related]
2. [Immunotherapy of human retinoblastoma with RGNTF-monoclonal antibody using nude mice as model]. Ren F; Zhou MH Zhonghua Zhong Liu Za Zhi; 1992 Sep; 14(5):323-6. PubMed ID: 1291287 [TBL] [Abstract][Full Text] [Related]
3. [Anti-retinoblastoma reaction developed in vivo through immunization of retinal ganglion neuronotrophic factor]. Chau RM; Ren F Yan Ke Xue Bao; 1993 Jun; 9(2):55-60. PubMed ID: 8276090 [TBL] [Abstract][Full Text] [Related]
4. [Preparation of anti-human retinoblastoma monoclonal antibody by solid tumor cell immunization and study on characteristics of its antigen]. Zhong X; Li Y; Ning B; Yan J; Li Y; Luo G; Lin J; Ying F; Feng G Zhonghua Yan Ke Za Zhi; 2002 Nov; 38(11):691-4. PubMed ID: 12487903 [TBL] [Abstract][Full Text] [Related]
5. Changes in rat retinal ganglion neuronotrophic factor and its mRNA during postnatal development. Zhou MH; Ren F; Qiu PX Sci China B; 1993 Mar; 36(3):305-13. PubMed ID: 8397801 [TBL] [Abstract][Full Text] [Related]
6. [Characteristics and inhibitory action of monoclonal and polyclonal antibodies against the retinal ganglion neuronotrophic factor (RGNTF)]. Zhou MH; Ren F; Zhao LP; Qiu PX Shi Yan Sheng Wu Xue Bao; 1991 Sep; 24(3):293-5. PubMed ID: 1755266 [TBL] [Abstract][Full Text] [Related]
7. An abnormal response of retinoblastoma cells (Y-79) to neurotrophins. Wagner N; Wagner KD; Sefton M; Rodríguez-Tébar A; Grantyn R Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1932-9. PubMed ID: 10845619 [TBL] [Abstract][Full Text] [Related]
8. [Effects of harmaline and fluorouracil (5-FU) on human retinoblastoma cell line SO-Rb 50]. Jin YJ Zhonghua Yan Ke Za Zhi; 1990 Sep; 26(5):286-8. PubMed ID: 2086140 [TBL] [Abstract][Full Text] [Related]
9. Effect of butyrate and corticosteroids on retinoblastoma in vitro and in vivo. Howard MA; Wardwell S; Albert DM Invest Ophthalmol Vis Sci; 1991 May; 32(6):1711-3. PubMed ID: 2032794 [TBL] [Abstract][Full Text] [Related]
10. In vitro effects of prostaglandins on human retinoblastoma cell line, Y-79 cells. Nakamura M; Koshihara Y; Fujino Y; Mochizuki M; Minoda K; Masuda K Jpn J Ophthalmol; 1987; 31(4):598-607. PubMed ID: 3129606 [TBL] [Abstract][Full Text] [Related]
11. Subcellular localization of the retinoblastoma protein. Szekely L; Uzvolgyi E; Jiang WQ; Durko M; Wiman KG; Klein G; Sumegi J Cell Growth Differ; 1991 Jun; 2(6):287-95. PubMed ID: 2064997 [TBL] [Abstract][Full Text] [Related]
12. [Establishment and characterization of a human retinoblastoma cell line SO-Rb50]. Yi YZ; Jie J Zhonghua Yan Ke Za Zhi; 1990 Nov; 26(6):355-9. PubMed ID: 2086157 [TBL] [Abstract][Full Text] [Related]
13. Basic fibroblast growth factor is present in cultured human retinoblastoma cells. Schweigerer L; Neufeld G; Gospodarowicz D Invest Ophthalmol Vis Sci; 1987 Nov; 28(11):1838-43. PubMed ID: 3667155 [TBL] [Abstract][Full Text] [Related]
18. Effects of the augmenter of liver regeneration on the biological behavior of hepatocellular carcinoma. Tang L; Sun H; Zhang L; Deng JC; Guo H; Zhang L; Liu Q Saudi Med J; 2009 Aug; 30(8):1001-9. PubMed ID: 19668879 [TBL] [Abstract][Full Text] [Related]
19. Paradoxical increase in retinoblastoma protein in colorectal carcinomas may protect cells from apoptosis. Yamamoto H; Soh JW; Monden T; Klein MG; Zhang LM; Shirin H; Arber N; Tomita N; Schieren I; Stein CA; Weinstein IB Clin Cancer Res; 1999 Jul; 5(7):1805-15. PubMed ID: 10430085 [TBL] [Abstract][Full Text] [Related]
20. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix. Inamoto T; Yamochi T; Ohnuma K; Iwata S; Kina S; Inamoto S; Tachibana M; Katsuoka Y; Dang NH; Morimoto C Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3470-7. PubMed ID: 16740772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]